JiangSu Bicon Pharmaceutical Listed Co operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares JiangSu Bicon Pharmaceutical Listed Co with three other
companies in this sector in China:
Chengdu Kanghong Pharmaceuticals Group Co Ltd
sales of 2.07 billion Chinese Renmimbi [US$307.70 million]
of which 100%
was Pharmaceutical Manufacturing),
Real Nutriceutical Group Ltd
(2.05 billion Chinese Renmimbi [US$304.30 million]
of which 67%
was Health and nutritional supplements), and
Heilongjiang ZBD Pharmaceutical Co Ltd
(2.07 billion Chinese Renmimbi [US$307.53 million]
of which 95%
was Pharmaceutical Industry).
During the year ended December of 2015, sales at
JiangSu Bicon Pharmaceutical Listed Co were 2.02 billion Chinese Renmimbi (US$300.16 million).
increase of 90.8%
versus 2014, when the company's sales were 1.06 billion Chinese Renmimbi.
Sales of Pharmaceutical Intermediates saw an increase
that was more than double the company's growth rate: sales were up
200.4% in 2015, from
673.54 million Chinese Renmimbi to 2.02 billion Chinese Renmimbi.
Not all segments of JiangSu Bicon Pharmaceutical Listed Co experienced an increase in sales in 2015:
sales of Other fell 99.8% to 52,892.36 Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).